Nurix Therapeutics, Inc. (NRIX)
16.32
+0.40
(+2.55%)
USD |
NASDAQ |
Apr 14, 16:00
16.32
0.00 (0.00%)
After-Hours: 20:00
Nurix Therapeutics Profit Margin (Quarterly) : -1.39K% for Feb. 28, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 47.99% |
| Scholar Rock Holding Corp. | -- |
| Stoke Therapeutics, Inc. | -4.13K% |
| Immunome, Inc. | -- |
| Gilead Sciences, Inc. | 27.44% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.63% |
| Return on Assets | -48.13% |
| Return on Invested Capital | -57.45% |
| Gross Profit Margin (Quarterly) | 39.60% |
| Operating Margin (Quarterly) | -1.48K% |
| Return on Net Operating Assets | -410.5% |